Effects of Metformin as Add-On Therapy against Glioblastoma: An Old Medicine for Novel Oncology Therapeutics

SIMPLE SUMMARY: Glioblastoma is the most common and malignant primary brain tumor, with a median survival of around 14 months. The aggressiveness of glioblastoma is due to intense cell proliferation, angiogenesis, invasiveness, genetic instability, resistance to therapies and high frequency of relap...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarnaccia, Laura, Navone, Stefania E., Masseroli, Matteo M., Balsamo, Melissa, Caroli, Manuela, Valtorta, Silvia, Moresco, Rosa M., Campanella, Rolando, Schisano, Luigi, Fiore, Giorgio, Galiano, Valentina, Garzia, Emanuele, Appiani, Giuseppe C., Locatelli, Marco, Riboni, Laura, Marfia, Giovanni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946812/
https://www.ncbi.nlm.nih.gov/pubmed/35326565
http://dx.doi.org/10.3390/cancers14061412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946812/
https://www.ncbi.nlm.nih.gov/pubmed/35326565
http://dx.doi.org/10.3390/cancers14061412

Ejemplares similares